Literature DB >> 8282002

Differential down-regulation of pulmonary beta 1- and beta 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline.

M Nishikawa1, J C Mak, H Shirasaki, P J Barnes.   

Abstract

The down-regulation by isoprenaline of beta 1 and beta 2-adrenoceptors in rat lung was investigated at the receptor protein and messenger RNA level. Rats were treated with either isoprenaline or vehicle for 2 h, 1 day and 7 days. Isoprenaline treatment resulted in significant decreases of both beta 1- and beta 2-adrenoceptor density after 1 day with maximal decreases of 65 +/- 7 and 65 +/- 5% for beta 1- and beta 2-adrenoceptors, respectively, at 7 days. The administration of isoprenaline had no effect on binding affinities of either beta 1 or beta 2-adrenoceptors. beta 1-Adrenoceptor mRNA was significantly decreased by 58 +/- 10, 73 +/- 4 and 51 +/- 11% at 2 h, 1 day and 7 days, respectively, after isoprenaline treatment. However, the beta 2-adrenoceptor mRNA was not changed at 2 h after treatment and was significantly decreased by 35 +/- 11 and 45 +/- 12% at 1 day and 7 days, respectively after treatment. This time course of beta 2-adrenoceptor mRNA correlated well with that of the transcription factor cyclic AMP response element binding protein-like DNA binding activity, determined by gel shift assay. These findings indicate the existence of distinct mechanisms for down-regulation of beta 1- and beta 2-adrenoceptors and suggest the involvement of cyclic AMP response element binding protein in the down-regulation of beta 2-adrenoceptors in rat lung.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282002     DOI: 10.1016/0922-4106(93)90070-p

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha).

Authors:  P A Finney; L E Donnelly; M G Belvisi; T T Chuang; M Birrell; A Harris; J C Mak; C Scorer; P J Barnes; I M Adcock; M A Giembycz
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle.

Authors:  Stefano Fogli; Silvia Pellegrini; Barbara Adinolfi; Veronica Mariotti; Erika Melissari; Laura Betti; Laura Fabbrini; Gino Giannaccini; Antonio Lucacchini; Claudio Bardelli; Fabio Stefanelli; Sandra Brunelleschi; Maria Cristina Breschi
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo.

Authors:  P A Finney; M G Belvisi; L E Donnelly; T T Chuang; J C Mak; C Scorer; P J Barnes; I M Adcock; M A Giembycz
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.

Authors:  J C Mak; M Nishikawa; H Shirasaki; K Miyayasu; P J Barnes
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Desensitization of beta-adrenergic receptors in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog.

Authors:  Syeda M Kabir; Shyamali Mukherjee; Veera Rajaratnam; Milton G Smith; Salil K Das
Journal:  J Biochem Mol Toxicol       Date:  2009 Jan-Feb       Impact factor: 3.642

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.